Yunnan Baiyao Group News and Activities
Presence
Yunnan Baiyao Group makes pharmaceutical and health products. Its main products include medicines, oral care products, and wellness goods for consumers, pharmacies, hospitals, and healthcare providers.
Yunnan Baiyao Group products and services overview:
- Prescription drugs
- Traditional medicines
- Oral care
- Health supplements
- Medical devices
- Personal care
Revenue: ~$5 billion
Employees: 12,000
Headquarters: Kunming, China
Yunnan Baiyao Group is one of the...
Yunnan Baiyao Group is a company listed under the stock ticker 000538 (CN).
Executives
View the org chart displaying its 15 main executives
Most searched biographies at Yunnan Baiyao Group
- Ming Dong, President, Chief Executive Officer and Vice Chairman of...
- Yangfeng Cao, Independent Director
- Guanghui You, Director
Create your alert
to follow the executive moves at Yunnan Baiyao Group.
Pharmaceuticals
Yunnan Baiyao Group has 1,911 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).
Popular M&A news in Pharmaceuticals
- GNI has announced the acquisition of Ayumi Pharmaceutical (posted on June 12 2026).
- Parabilis Medicines has just announced a $670 Million fundraising (posted on June 11 2026).
- Chiesi has acquired Kalvista Pharmaceuticals (posted on June 11 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Yunnan Baiyao Group
Social media about Yunnan Baiyao Group
- Yunnan Baiyao Group on Wikipedia, Google News & Yahoo Finance
- Yunnan Baiyao Group on LinkedIn, X (Twitter) & YouTube
